Comparative Single- and Multiple-Dose Pharmacokinetics of Levodopa and 3-O-Methyldopa following a New Dual-Release and a Conventional Slow-Release Formulation of Levodopa and Benserazide in Healthy Volunteers

Publisher： Karger

E-ISSN： 1421-9913|49|1|39-44

ISSN： 0014-3022

Source： European Neurology, Vol.49, Iss.1, 2002-12, pp. : 39-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COMT Inhibition by Tolcapone Further Improves Levodopa Pharmacokinetics when Combined with a Dual-Release Formulation of Levodopa/Benserazide

By  

European Neurology, Vol. 41, Iss. 4, 1999-05 ,pp. : 206-211

Karger

Access to resources Recommend Favorite

Pharmacokinetic Studies with a Dual-Release Formulation of Levodopa, a Novel Principle in the Treatment of Parkinson’s Disease

By  

European Neurology, Vol. 39, Iss. 2, 1998-02 ,pp. : 119-124

Karger

Access to resources Recommend Favorite

Comparative Single-Dose Pharmacokinetics of Clonazepam following Intravenous, Intramuscular and Oral Administration to Healthy Volunteers

By  

European Neurology, Vol. 49, Iss. 3, 2003-03 ,pp. : 173-177

Karger

Access to resources Recommend Favorite

Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers

By Duijkers IJM  

Human Reproduction, Vol. 13, Iss. 9, 1998-09 ,pp. : 2392-2398

Oxford University Press

Access to resources Recommend Favorite

Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix

By Felberbaum RE  

Human Reproduction, Vol. 13, Iss. 6, 1998-06 ,pp. : 1660-1668

Oxford University Press

Access to resources Recommend Favorite